Population-scale sequencing resolves correlates and determinants of latent Epstein-Barr Virus infection.

Saved in:
Bibliographic Details
Title: Population-scale sequencing resolves correlates and determinants of latent Epstein-Barr Virus infection.
Authors: Nyeo SS; Computational and Systems Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Tri-Institutional Program in Computational Biology, Weill Cornell School of Medicine, New York, NY, USA., Cumming EM; Computational and Systems Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Burren OS; Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Pagadala MS; Computational and Systems Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Gutierrez JC; Computational and Systems Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Ali TA; Computational and Systems Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Tri-Institutional Program in Computational Biology, Weill Cornell School of Medicine, New York, NY, USA., Kida LC; Computational and Systems Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Chen Y; Medical Scientist Training Program, Baylor College of Medicine, Houston, TX, USA.; Jan and Dan Duncan Neurological Research Institute, Texas Children's Hospital, Houston, TX, USA., Hu F; Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Hollis B; Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Fabre M; Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., MacArthur S; Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Wang Q; Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Ludwig LS; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.; Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin Institute for Medical Systems Biology (BIMSB), Berlin, Germany., Dey KK; Computational and Systems Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Petrovski S; Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Dhindsa RS; Medical Scientist Training Program, Baylor College of Medicine, Houston, TX, USA.; Department of Pathology and Immunology, Baylor College of Medicine, Houston, TX, USA.; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA., Lareau CA; Computational and Systems Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Source: BioRxiv : the preprint server for biology [bioRxiv] 2025 Jul 18. Date of Electronic Publication: 2025 Jul 18.
Publication Type: Journal Article; Preprint
Journal Info: Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2692-8205
DOI:10.1101/2025.07.18.665549